— Know what they know.
Not Investment Advice
Also trades as: EDEN.L (LSE) · $vol 0M

EDNSF OTC

Eden Biosolutions PLC
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -50.0%
$0.04
+0.00 (+0.00%)
 
OTC · Basic Materials · Agricultural Inputs · Tech Score Sell · Power 41 · $28.1M mcap · 443M float · 0.0026% daily turnover
Credit Risk of going bust: not rated Debt: 2.6% of company value Bonds: none of note held by US funds details ▾
Not rated: no recent balance sheet.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Income Trends

Revenue
$4M +34.8% ▲
5Y CAGR: +18.7%
Gross Profit
$2M +6.0% ▲
5Y CAGR: +16.8%
Operating Income
-$2M -17.1% ▼
Net Income
-$2M +70.6% ▲
EPS (Diluted)
$-0.00 +76.6% ▲
EBITDA
-$2M +74.6% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$1M$1M$2M$3M$4M
YoY Growth-25.0%-10.3%+48.7%+74.7%+34.8%
Cost of Revenue$1M$1M$2M$1M$2M
Gross Profit$10K$28K$207K$2M$2M
Gross Margin0.7%2.3%11.3%55.3%43.5%
R&D Expenses$315K$215K$284K$0$0
SG&A Expenses$2M$3M$3M$3M$4M
Operating Expenses$2M$3M$3M$4M$4M
Operating Income-$2M-$3M-$3M-$2M-$2M
Operating Margin-163.9%-261.1%-140.5%-58.5%-50.8%
Interest Expense$24K$32K$22K$17K$10K
Income Before Tax-$3M-$3M-$3M-$7M-$2M
Tax Expense-$285K-$618K-$324K-$428K-$267K
Net Income-$2M-$3M-$2M-$6M-$2M
Net Margin-165.8%-227.0%-122.4%-203.5%-44.3%
EPS (Diluted)$-0.01$-0.01$-0.01$-0.02$-0.00
EBITDA-$2M-$3M-$2M-$6M-$2M
Shares Outstanding345M380M381M421M533M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms